Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis
... six month treatment period, elagolix 150 mg once
daily had minimal impact on BMD (-0.80% mean change ... change from baseline, spine). The 250 mg once
daily dose, as expected, had slightly greater ... six (-1.0% femur, -1.6% spine). The 150 mg once
daily BMD profile in this Lilac Petal Study is ...
Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily Injections
... injection port for people taking multiple
daily injections to include a disposable inserter, that ... want to minimize the intrusion of injections on
daily life, the i-port(R) is the only product of its ... for anyone who wants to minimize the intrusion of
daily injections.
The i-port(R) should not be ...
Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
... follicle stimulant achieves similar efficacy to
daily injections of follitropin beta given over a one ... follicle stimulating hormone (rFSH) given once
daily for seven days. The ENGAGE data was presented ... similar to that achieved in patients receiving a
daily dose of 200 IU rFSH (follitropin beta) for seven ...
Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials
... of 0.75% in patients
receiving 50mg twice
daily dose (p<0001) and 0.60 % in patients receiving 100
mg once
daily dose (p<.0001).
In a subgroup of ... receiving 100mg once daily
dose and 50mg twice
daily dose respectively, which compares favorably ...
Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
... group, one active sponge is administered on a
daily basis. Provisional findings from this trial have ... administered daily) is compared to once
daily 750mg oral levofloxacin (the current standard of care at its recommended maximum
daily dose) in a prospective, randomized design. The ...
Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA
... (AMEX: SVA ).
Investors can view all of the
daily stock alerts for free by visiting ... subscribe to our FREE newsletter filled with
daily trading ideas .
BeaconEquity.com is one ... in their research and due diligence by providing
daily trading ideas, and consolidating the publicly ...
Beacon Equity Issues Trade Alerts on Market Movers: CAH, LEAP, FISV, PBG, ARNA, LEN
... news today.
Investors can view all of the
daily trade alerts for free by visiting ... subscribe to our FREE newsletter filled with
daily trading ideas .
BeaconEquity.com is one ... in their research and due diligence by providing
daily trading ideas, and consolidating the publicly ...
FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)
... fumarate dihydrate) 160/4.5 mcg for the twice
daily maintenance treatment of airflow obstruction in ... that can deliver lung function improvement(3) and
daily symptom control, together with a rapid onset of ... can be difficult for a person to perform simple,
daily tasks.(4) As the disease progresses, people with ...
Beacon Equity Issues Technical Trade Alerts on Drug Manufacturer Stocks: FRX, TEVA, AGN, CEPH, VRTX, ADLR
... news today.
Investors can view all of the
daily trading notes for free by visiting: ... to subscribe to our FREE newsletter filled with
daily trading ideas by visiting: ... in their research and due diligence by providing
daily trading ideas, and consolidating the publicly ...
Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C
... of nitazoxanide at 675 mg or 1,350 mg twice
daily with food for seven days. This was a randomized, ... crossover study. The 675 mg and 1,350 mg twice
daily doses of controlled release nitazoxanide produced ... at 1,350 mg (n=16) or placebo (n=8) twice
daily for four weeks followed by the same regimen plus ...
InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
... Patients were randomized 1:1 to receive a total
daily dose of 2403 mg pirfenidone, or placebo. ... patients were randomized 2:2:1 to receive a total
daily dose of 2403 mg pirfenidone, or placebo, or a total
daily dose of 1197 mg pirfenidone, respectively, ...
Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
... at two different doses, 300 mg twice
daily (BID) and 450 mg BID; the comparator was ... was effective at doses as low as 200 mg once
daily in patients with community-acquired pneumonia ... was as efficacious as levofloxacin, 500 mg once
daily for 7 days.
About cSSSI
Complicated ...
Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C
... find it challenging to participate in normal
daily activities, especially in the days following dose ... alfa-2b administered every four weeks plus
daily ribavirin in treatment-naive patients with ... All patients in the study will receive 800-mg
daily oral ribavirin. The total duration of treatment ...
Multiple Vimpat(R) (lacosamide) Studies Presented at American Epilepsy Society Annual Meeting
... by the FDA. In clinical
trials, the 600 mg
daily dose was not more effective than the 400 mg ... Vimpat(R) dosing should start at 50 mg twice
daily and maybe
increased to a
daily dose of 200 to 400 mg per day (recommended ...
ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments
... ZhnSpa introduces silk cloth facial masks for
daily or weekly use to the US and Canadian markets. ... and clarifying Dermocapsule™ serums for
daily use. "Taking excellent care of one's skin ... facial. Used independently, they enhance one's
daily skincare regime and address specific skin ...
Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile
... state assessment of NKO(R) in a low physiological
daily dose and compare it to well-established ... formulations standardized to a low physiological
daily dose of 500 mg NKO(R). Concentrations of the ... of EPA and DHA even at unprecedented low
daily dose and b) achieves a significantly higher ...
Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis
... reaching,
gripping and other activities of
daily living).
At week 24, the proportion of patients ... assesses
self-reported fatigue and its impact on
daily activities and function.
Improvements Seen in ... addition to joint pain and
swelling, RA may make
daily functioning difficult and is ...
Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
... (insulin glargine (rDNA
origin) injection) once
daily (basal insulin) and APIDRA(R) once ... glucose level, and randomised
to APIDRA(R) once
daily + LANTUS(R) once
daily + oral hypoglycaemic agents
(LANTUS(R) as basal ...
NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population
... of ESRD
patients who have been receiving
daily home hemodialysis, which includes
correlation ... among the NxStage
patient population undergoing
daily therapy vs. reported figures for
conventional, ... and geographic
location are participating in home
daily hemodialysis, indicating its ...
New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
... patients were randomized 2:1 to receive twice
daily treatment with
two inhalations of ... dose at 160/4.5 micrograms (mcg) (N=698)
or twice
daily treatment with one inhalation of ... therapy adjustable dose (N=330) at either once
daily treatment
with two inhalations of 160/4.5 mcg, ...
Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
... that Sustenex(TM), its all-natural
daily probiotic supplement is
now available nationwide. ... that gets the job done," continued
Pratt.
"A
daily probiotic supplement helps achieve a balance in ... probiotics need to become part of our
daily health
regimen," Davis continued.
Recently, Dr. ...
ALCiS(R) Daily Relief Now Available at Walgreens
... over-the-counter
topical pain relief cream, ALCiS
daily Relief, at all of its 6,237 stores.
Its ... said, "I'm pleased
with the reception ALCiS
daily Relief is getting by consumers and health
care ... program.
"My patients who have used ALCiS
daily Relief have told me that they
love this product," ...
US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
... The revenue
increase reflects an increase in
daily visits due to growth in our network
of affiliated ... or 23.7 percent, both reflecting an increase in
daily visits. Also
contributing to the medical oncology ... 12.4 1,164 3.0 1,199 1,067 12.4
daily Operating Statistics: Medical oncology ...
Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial
... repeat oral doses of SLx-4090 either three times
daily or once
daily for 14 days. The Company intends to ... oral dose
of 200 mg of SLx-4090 or placebo once
daily or three times
daily for 14
days. Postprandial triglycerides were ...
DeviceSpace.com Launches Marketing Campaign for US Medical Device Industry
... (http://www.devicespace.com ) delivers
daily online
careers, news, event, company and other ... ), which presents critical
daily medical
device industry news, careers and ... "DeviceSpace.com will continue to deliver
daily careers, news
and other information relevant to ...
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
... a
lower recommended starting dose of 100 mg once
daily and safety and
efficacy data in a greater number ... recommended starting dose of SPRYCEL 100 mg once
daily based on a dose-optimization trial - the ... trial in this patient population. This once
daily dose was associated with a lower frequency of ...
FDA Approves Administration of LEXIVA(R) with Lower Dose of 'Boosting' Medication Ritonavir
... that reducing the
number of pills taken
daily is an important consideration for ... Therapy naive adults -- LEXIVA 1400mg twice
daily -- LEXIVA 1400mg once
daily plus ritonavir 100mg ...
Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
... that,
patients who received ZD4054 10 mg once
daily had a median OS of 24.5
months, patients who received ZD4054 15 mg once
daily had a median OS of
23.5 months and the placebo ... arms: 15 mg ZD4054 once daily; 10 mg ZD4054 once
daily or a
placebo tablet once daily. In addition to ...
FDA Accepts Sucampo's sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
... patients received
lubiprostone 8 mcg twice
daily or placebo twice
daily over a 12-week
period. Patients receiving ... About AMITIZA(R) (lubiprostone 24 mcg) Twice
daily for Chronic
Idiopathic Constipation AMITIZA (24 ...
NxStage Reports Second Quarter 2009 Financial Results
... market acceptance and demand for NxStage's products, growth in home and/or
daily hemodialysis, unanticipated difficulties in achieving operational efficiencies and cost reductions, changes in reimbursement for home and
daily hemodialysis, changes in the regulatory environment, changes in the ...
Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
... radezolid was administered orally at three different doses: 300 mg once
daily (QD), 450 mg QD and 450 mg twice
daily (BID). This novel oxazolidinone showed comparable efficacy across all ...
Sunesis Reports Financial Results for the Second Quarter 2009
... four with cytarabine given either as a continuous infusion of 400 mg/m2
daily for five days (CIV Schedule) or as a two hour IV bolus of 1 g/m2
daily for five days (Bolus Schedule). Across both the CIV and Bolus Schedules, a ...
SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
... were initially randomized in the core study to SAPHRIS 5 to 10 mg twice
daily or olanzapine 5 to 20 mg once
daily for 26 weeks. In the core study, both SAPHRIS and olanzapine reduced ...
Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease
... that found caregivers reported experiencing increased disruption in
daily schedules, greater lack of family support, and more time devoted to being ... and ability to learn, reason, make judgments, communicate and carry out
daily activities, such as bathing and eating.( )As Alzheimer's disease ...
Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease
... the Alzheimer's Association.
During this study, patients received
daily administration of either AC-1202 or placebo for 90 days, with efficacy ... termination of AC-1202 treatment (p=0.034). This finding suggests that
daily administration of AC-1202 may produce lasting effects in those patients ...
Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)
... and efficacy of albinterferon alfa-2b administered every four weeks plus
daily ribavirin in treatment-naive patients with genotypes 2 and 3 chronic ... dose once every week. All patients in the study will receive 800-mg
daily oral ribavirin. The total duration of treatment will be 24 weeks. The ...
SEP Signs REGURIN(R) Deal
... also obtained exclusive rights to a new presentation of Regurin,
the once
daily Regurin XL. The availability of Regurin XL will enable it to
compete more ... D, Sand P, Zinner N and Dmochowsky R. for the Trospium Study
Group: Once
daily trospium chloride is effective and well tolerated for the
treatment of ...
Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures
... trial conducted to investigate the efficacy, tolerability, and safety of
daily INFERGEN at dosages of 9 and 15 mcg/day administered with
daily weight-based RBV. The study tested 2 dosages of INFERGEN in 487 documented ...
New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives
... Three-of-Four Patients Surveyed Experience
daily Pain From Rheumatoid Arthritis Despite Current Treatment; Findings ... methods for obtaining information and support for the management of RA,
daily living with RA, and patients' beliefs around their current treatment.
...
AEterna Zentaris Discloses Preliminary Phase 2 Trial Results for Perifosine in Combination with Radiotherapy for Non-Small Cell Lung Cancer
... NSCLC, mainly Stage III, received a 5-week course of 150 mg perifosine
daily or placebo. After end of radiotherapy, patients were followed up to ... non-small cell lung cancer study design, perifosine is dosed 50mg or 100mg
daily until progression. Recently, positive Phase 2 data for multiple myeloma ...